PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33248230-4	2021	Our results showed that both octreotide and pasireotide reduced TT cell proliferation (-35.2+-12.1%, p<0.001, and -25.3+-24.8%, p<0.05, at 10-8 M, respectively), with concomitant inhibition of ERK phosphorylation and cyclin D1 expression.	Octreotide	29-39	cyclin D1	Homo sapiens	217-226	
26015296-10	2015	Octreotide not only reversed everolimus-induced Akt phosphorylation but also displayed additive and complementary effects with everolimus on downstream proteins involved in translation (4EB-P1), and controlling cell cycle (p27Kip1 and cyclin D1).	Octreotide	0-10	cyclin D1	Homo sapiens	235-244	
24634935-8	2013	RESULTS: Octreotide treatment increased SSTR2,SSTR5-induced apoptosis of SW480 colon cancer cells, promoted the plasma membrane accumulation of beta-catenin, inactivated T-cell factor-dependent transcription, and downregulated Wnt target genes cyclin D1 and c-Myc.	Octreotide	9-19	cyclin D1	Homo sapiens	244-253